| UniProt ID | F262_HUMAN | |
|---|---|---|
| UniProt AC | O60825 | |
| Protein Name | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 | |
| Gene Name | PFKFB2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 505 | |
| Subcellular Localization | ||
| Protein Description | Synthesis and degradation of fructose 2,6-bisphosphate.. | |
| Protein Sequence | MSGASSSEQNNNSYETKTPNLRMSEKKCSWASYMTNSPTLIVMIGLPARGKTYVSKKLTRYLNWIGVPTKVFNLGVYRREAVKSYKSYDFFRHDNEEAMKIRKQCALVALEDVKAYLTEENGQIAVFDATNTTRERRDMILNFAEQNSFKVFFVESVCDDPDVIAANILEVKVSSPDYPERNRENVMEDFLKRIECYKVTYRPLDPDNYDKDLSFIKVINVGQRFLVNRVQDYIQSKIVYYLMNIHVQPRTIYLCRHGESEFNLLGKIGGDSGLSVRGKQFAQALRKFLEEQEITDLKVWTSQLKRTIQTAESLGVPYEQWKILNEIDAGVCEEMTYAEIEKRYPEEFALRDQEKYLYRYPGGESYQDLVQRLEPVIMELERQGNVLVISHQAVMRCLLAYFLDKGADELPYLRCPLHTIFKLTPVAYGCKVETIKLNVEAVNTHRDKPTNNFPKNQTPVRMRRNSFTPLSSSNTIRRPRNYSVGSRPLKPLSPLRAQDMQEGAD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSGASSSEQ ------CCCCCCCCC | 42.96 | 22814378 | |
| 2 | Phosphorylation | ------MSGASSSEQ ------CCCCCCCCC | 42.96 | 25159151 | |
| 5 | Phosphorylation | ---MSGASSSEQNNN ---CCCCCCCCCCCC | 37.61 | 25159151 | |
| 6 | Phosphorylation | --MSGASSSEQNNNS --CCCCCCCCCCCCC | 37.04 | 25159151 | |
| 7 | Phosphorylation | -MSGASSSEQNNNSY -CCCCCCCCCCCCCC | 40.48 | 25159151 | |
| 13 | Phosphorylation | SSEQNNNSYETKTPN CCCCCCCCCCCCCCC | 26.86 | 25159151 | |
| 14 | Phosphorylation | SEQNNNSYETKTPNL CCCCCCCCCCCCCCC | 29.73 | 20860994 | |
| 16 | Phosphorylation | QNNNSYETKTPNLRM CCCCCCCCCCCCCCC | 31.80 | 24043423 | |
| 17 | Ubiquitination | NNNSYETKTPNLRMS CCCCCCCCCCCCCCC | 50.47 | 24816145 | |
| 24 | Phosphorylation | KTPNLRMSEKKCSWA CCCCCCCCCCCCHHH | 39.57 | 25159151 | |
| 29 | Phosphorylation | RMSEKKCSWASYMTN CCCCCCCHHHHHHCC | 34.26 | 20068231 | |
| 32 | Phosphorylation | EKKCSWASYMTNSPT CCCCHHHHHHCCCCE | 14.80 | 29116813 | |
| 33 | Phosphorylation | KKCSWASYMTNSPTL CCCHHHHHHCCCCEE | 10.54 | 29116813 | |
| 35 | Phosphorylation | CSWASYMTNSPTLIV CHHHHHHCCCCEEEE | 25.06 | 29116813 | |
| 37 | Phosphorylation | WASYMTNSPTLIVMI HHHHHCCCCEEEEEE | 15.31 | 29116813 | |
| 39 | Phosphorylation | SYMTNSPTLIVMIGL HHHCCCCEEEEEEEC | 29.01 | 29116813 | |
| 52 | Phosphorylation | GLPARGKTYVSKKLT ECCCCCCHHHHHHHH | 31.79 | 20068231 | |
| 53 | Phosphorylation | LPARGKTYVSKKLTR CCCCCCHHHHHHHHH | 13.25 | 20068231 | |
| 55 | Phosphorylation | ARGKTYVSKKLTRYL CCCCHHHHHHHHHHH | 17.41 | 20068231 | |
| 59 | Phosphorylation | TYVSKKLTRYLNWIG HHHHHHHHHHHHHHC | 26.58 | 21964256 | |
| 63 | Ubiquitination | KKLTRYLNWIGVPTK HHHHHHHHHHCCCCE | 21.27 | 23000965 | |
| 84 | Phosphorylation | YRREAVKSYKSYDFF CCHHHHHHHCCCCCC | 31.06 | 24719451 | |
| 86 | Ubiquitination | REAVKSYKSYDFFRH HHHHHHHCCCCCCCC | 50.02 | 29967540 | |
| 100 | Ubiquitination | HDNEEAMKIRKQCAL CCCHHHHHHHHHHHH | 46.54 | 24816145 | |
| 103 | Ubiquitination | EEAMKIRKQCALVAL HHHHHHHHHHHHHHH | 53.88 | 29967540 | |
| 113 | Ubiquitination | ALVALEDVKAYLTEE HHHHHHHHHHHEECC | 2.52 | 24816145 | |
| 130 | Phosphorylation | QIAVFDATNTTRERR EEEEEECCCCCHHHH | 34.64 | 22210691 | |
| 132 | Phosphorylation | AVFDATNTTRERRDM EEEECCCCCHHHHHH | 23.91 | 22210691 | |
| 133 | Phosphorylation | VFDATNTTRERRDMI EEECCCCCHHHHHHH | 32.38 | 22210691 | |
| 174 | Phosphorylation | NILEVKVSSPDYPER EEEEEEECCCCCCHH | 30.36 | 26270265 | |
| 175 | Phosphorylation | ILEVKVSSPDYPERN EEEEEECCCCCCHHC | 25.44 | 26462736 | |
| 192 | Ubiquitination | NVMEDFLKRIECYKV CHHHHHHHHHCEEEE | 51.85 | 29967540 | |
| 211 | Ubiquitination | LDPDNYDKDLSFIKV CCCCCCCCCCCEEEE | 50.65 | 29967540 | |
| 214 | Phosphorylation | DNYDKDLSFIKVINV CCCCCCCCEEEEEEC | 34.75 | 24719451 | |
| 275 | Phosphorylation | IGGDSGLSVRGKQFA ECCCCCCCHHHHHHH | 17.19 | 24719451 | |
| 279 | Ubiquitination | SGLSVRGKQFAQALR CCCCHHHHHHHHHHH | 31.51 | 29967540 | |
| 287 | Ubiquitination | QFAQALRKFLEEQEI HHHHHHHHHHHHHCC | 55.97 | 29967540 | |
| 298 | Ubiquitination | EQEITDLKVWTSQLK HHCCCCHHHHHHHHH | 38.24 | 29967540 | |
| 305 | Ubiquitination | KVWTSQLKRTIQTAE HHHHHHHHHHHHHHH | 39.60 | 23000965 | |
| 355 | Ubiquitination | FALRDQEKYLYRYPG HHCCCHHHHHHCCCC | 34.62 | 24816145 | |
| 356 | Phosphorylation | ALRDQEKYLYRYPGG HCCCHHHHHHCCCCC | 14.28 | 22817900 | |
| 358 | Phosphorylation | RDQEKYLYRYPGGES CCHHHHHHCCCCCCC | 12.66 | 22817900 | |
| 366 | Phosphorylation | RYPGGESYQDLVQRL CCCCCCCHHHHHHHH | 11.18 | 22817900 | |
| 458 | Phosphorylation | NNFPKNQTPVRMRRN CCCCCCCCCCCCCCC | 32.90 | 30576142 | |
| 463 (in isoform 2) | Phosphorylation | - | 24.86 | 27273156 | |
| 466 (in isoform 2) | Phosphorylation | - | 28.78 | 22617229 | |
| 466 | Phosphorylation | PVRMRRNSFTPLSSS CCCCCCCCCCCCCCC | 28.78 | 29255136 | |
| 468 | Phosphorylation | RMRRNSFTPLSSSNT CCCCCCCCCCCCCCC | 24.12 | 22167270 | |
| 471 | Phosphorylation | RNSFTPLSSSNTIRR CCCCCCCCCCCCCCC | 32.68 | 23927012 | |
| 472 | Phosphorylation | NSFTPLSSSNTIRRP CCCCCCCCCCCCCCC | 34.98 | 25159151 | |
| 472 | O-linked_Glycosylation | NSFTPLSSSNTIRRP CCCCCCCCCCCCCCC | 34.98 | 31373491 | |
| 473 | Phosphorylation | SFTPLSSSNTIRRPR CCCCCCCCCCCCCCC | 34.32 | 23927012 | |
| 475 | Phosphorylation | TPLSSSNTIRRPRNY CCCCCCCCCCCCCCC | 20.15 | 23927012 | |
| 482 | Phosphorylation | TIRRPRNYSVGSRPL CCCCCCCCCCCCCCC | 13.15 | 27273156 | |
| 483 | Phosphorylation | IRRPRNYSVGSRPLK CCCCCCCCCCCCCCC | 24.45 | 22167270 | |
| 486 | Phosphorylation | PRNYSVGSRPLKPLS CCCCCCCCCCCCCCC | 28.68 | 23927012 | |
| 493 | Phosphorylation | SRPLKPLSPLRAQDM CCCCCCCCCCCHHHH | 30.34 | 29255136 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 29 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
| 466 | S | Phosphorylation | Kinase | AMPK | Q9Y478 | Uniprot |
| 466 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
| 466 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| 466 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 466 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
| 466 | S | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
| 466 | S | Phosphorylation | Kinase | AMPK_GROUP | - | PhosphoELM |
| 466 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
| 483 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| 483 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
| 483 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of F262_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of F262_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| 1433T_HUMAN | YWHAQ | physical | 12853467 | |
| PDE4D_HUMAN | PDE4D | physical | 26496610 | |
| RO52_HUMAN | TRIM21 | physical | 26496610 | |
| ZC11A_HUMAN | ZC3H11A | physical | 26496610 | |
| SRRM2_HUMAN | SRRM2 | physical | 26496610 | |
| PGAP2_HUMAN | PGAP2 | physical | 26496610 | |
| NO40_HUMAN | ZCCHC17 | physical | 26496610 | |
| RMD3_HUMAN | RMDN3 | physical | 26496610 | |
| RBM15_HUMAN | RBM15 | physical | 26496610 | |
| CPSF7_HUMAN | CPSF7 | physical | 26496610 | |
| DOCK8_HUMAN | DOCK8 | physical | 26496610 | |
| PDIP3_HUMAN | POLDIP3 | physical | 26496610 | |
| SARNP_HUMAN | SARNP | physical | 26496610 | |
| FA83B_HUMAN | FAM83B | physical | 26496610 | |
| CBY1_HUMAN | CBY1 | physical | 27173435 | |
| RAB3I_HUMAN | RAB3IP | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; THR-468; SER-483AND SER-493, AND MASS SPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466, AND MASSSPECTROMETRY. | |
| "Phosphorylation and activation of heart PFK-2 by AMPK has a role inthe stimulation of glycolysis during ischaemia."; Marsin A.S., Bertrand L., Rider M.H., Deprez J., Beauloye C.,Vincent M.F., Van den Berghe G., Carling D., Hue L.; Curr. Biol. 10:1247-1255(2000). Cited for: PHOSPHORYLATION AT SER-466, AND MUTAGENESIS OF SER-466. | |